Coalition Asks Senate to Focus on Patient Access to Care
Coalition tells Senate committee that real patient interests trump potential “conflicts of interest” as nation expands access to care.
Feb. 3, 2012 – There are just 10 days left to comment on an FDA draft report that explores the ... read more
Feb. 2, 2012 – More than four hours of testimony before the House Energy and Commerce Committee’s Subcommittee on Health ... read more
Jan. 27, 2012 – The Digital Advertising Alliance (DAA) last week launched its “Your AdChoices” public education campaign to inform ... read more
Jan. 26, 2012 – Avoiding conflict of interest in continuing medical education (CME) may seem like a daunting task, but ... read more
Jan. 20, 2012 – Common sense should tell people that some of celebrity chef Paula Deen’s infamously unhealthy dishes – ... read more
By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Jan. 17, 2012 – The Affordable Care Act ... read more
Jan. 6, 2012 — This article, written by Coalition for Healthcare Communication Executive Director John Kamp, was featured in the ... read more
Jan. 6, 2011 – As the pharmaceutical industry begins 2012, the FDA’s Office of Prescription Drug Promotion (OPDP) recommends that ... read more
Jan. 2, 2012 – In the waning days of 2011, the FDA released a significant draft guidance on company responses to ... read more
Dec. 15, 2011 – The Centers for Medicare & Medicaid Services (CMS) issued its long-awaited Proposed Rule for implementing the Physician ... read more
Dec. 12, 2011 — Facing a need to decrease spending and boost revenues, the federal government will continue to target ... read more
By Jack E. Angel, Education Foundation Executive Director, Coalition for Healthcare Communication Nov. 14, 2011 — In response to ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication – Nov. 7, 2011 – Until the research labs and ... read more
Oct. 24, 2011 – After the U.S. Supreme Court struck down speaker- and content-based restrictions in Sorrell v. IMS Health, ... read more
Oct. 18, 2011 – A case filed by Par Pharmaceutical, Inc. against the FDA seeks to preserve Par’s First Amendment ... read more
Dec. 14, 2011 — UPDATE — CMS has published the proposed rules enforcing the Sunshine provisions of the Affordable Care ... read more
By John Kamp, Coalition for Healthcare Communication Executive Director Sept. 13, 2011 — Debates over health care and related ... read more
Aug. 1, 2011 — The recent Supreme Court decision in Sorrell v. IMS Health Inc. is earning robust commentary in ... read more
By Kenneth P. Berkowitz, Esq. July 21, 2011 — Why does the government fail to apply current regulatory requirements and ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication July 18, 2011 — For those who have not read the ... read more
By John Kamp, Executive Director, Coalition for Healthcare Communication June 29, 2011 — Yesterday I had the pleasure of moderating ... read more
March 31, 2011 — At a time when interaction between biopharmaceutical companies and physicians is under increased scrutiny, a recent ... read more
Coalition tells Senate committee that real patient interests trump potential “conflicts of interest” as nation expands access to care.
From DTC Perspectives:
Representatives John Fleming and Frank Pallone set Erin Burnett of CNBC straight on the value of DTC and why removing its tax deductibility is not a good idea.
Washington lobbyists working with the Advertising Coalition breathed a bit easier Friday when learning that the Ad Tax Provision was not likely to be in the House revenue options for funding healthcare reform. But watch the news carefully.
Read more
The Advertising Coalition and the AAAA D.C. office report that elimination of the tax deduction for marketing costs for drug and related businesses is still among the revenue options to pay for healthcare reform (HCR).
Read more
The Coalition has developed an aggressive plan to address the FDA’s recent “draft guidance” for including risk information in advertising and other marketing materials.
Under the leadership of Harry Sweeney, the Coalition has developed an aggressive plan to address the FDA’s recent “draft guidance” for presenting risk information in advertising and other marketing materials.
Read more
Read the Coalition’s Amici Brief, submitted to appeals court, defending marketing use of prescription data and asserting First Amendment rights.
The American Association of Advertising Agencies, along with other members of The Advertising Coalition, are aggressively opposing all efforts to restrict the deductibility of prescription drug advertisements. The deductibility proposal, which has been discussed in Congress and at The White House, is an area of a new revenue package being considered as part of a new healthcare reform.
The Advertising Coalition, of which the 4A’s is a founding member, is coordinating the industry’s efforts to defeat any changes to the deductibility rules. The broad coalition comprises marketers, clients and media outlets.
Download the Letter Sent by The Advertising Coalition to President Obama
“This is a very real and an extremely serious threat,” said Dick O’Brien, head of the 4A’s Washington office. O’Brien and other 4A’s staff and members with medical accounts have been meeting with Congressional leaders and key members of the House Ways and Means Committee and the Senate Finance Committee to educate them about the effect such a change would have on consumers and on marketers and media.
For more information about the 4A’s efforts, contact the 4A Washington office, 202-331-7345.
Recent Comments